Concord Ventures
VC Fund
Herzliya, Israel
Concord Ventures is a venture capital firm offering exceptional entrepreneurs the capital, guidance and industry contacts necessary to build successful companies, at the forefront of their technology sector.With over ten years of leadership in the Israeli venture capital market, and with a dedicated group of highly experienced partners,Concord is well positioned to leverage and invest in the best Israeli-based technology companies and to provide attractive returns to its investors.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 15%
Last updated:
For AI agents: llms.txt
Industries Concord Ventures invests in
ManufacturingMedicalElectronicsInternetHealth Care
Stages Concord Ventures invests in
Series BSeries CSeries ASeries DFunding Round
Countries Concord Ventures invests in
United StatesIsrael
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Avi Domoshevizki
|
|||
|
Galit Makmal
|
|||
|
Isabelle Shai
|
|||
Jason Chao
|
|||
Matty Karp
|
Investment Focus
Industry
- Manufacturing 4 (31%)
- Medical 3 (23%)
- Electronics 3 (23%)
- Internet 2 (15%)
- Health Care 2 (15%)
Stage
- Series B 6 (46%)
- Series C 3 (23%)
- Series A 1 (8%)
- Series D 1 (8%)
- Funding Round 1 (8%)
Country
- United States 8 (62%)
- Israel 4 (31%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Avi Domoshevizki
General Partner
|
General Partner | Total investments: 0 | Find email | |
|
Galit Makmal
Accountant
|
Accountant | Total investments: 0 | Find email | |
|
Isabelle Shai
Administrative Manager
|
Administrative Manager | Total investments: 0 | Find email | |
|
Jason Chao
Team Member
|
Team Member | Total investments: 0 | Find email | |
|
Matty Karp
Founder and managing General Partner
|
Founder and managing General Partner | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ceres Nanosciences
|
Ceres Nanosciences Inc. (“Ceres”) is a privately held life sciences company engaged in the research, development, and commercialization of innovative sample preparation products, based on its proprietary Nanotrap® technology, which captures, enriches and preserves analytes/biomarkers. Early detection of biomarkers, in particular those of lowabundance, is key to the diagnosis and treatment of diseases such as cancer, cardiac, and infectious diseases, resulting in improved patient benefit and reduced health care costs. Ceres has a broad product pipeline of advanced sample collection technologies and diagnostics, funded through federal agency grants and industry collaboration funding. Ceres’ lead product in development is a direct antigen test for the diagnosis of Lyme disease, which will be available commercially in 2015. | $3M / Series A / Feb 02, 2017 | |
LightSand Communications
|
LightSand understands the business-critical needs of its customers and offers the highest quality technical support. They have a dedicated network of professional engineers and technicians who provide technical support to handle all hardware, software and professional service needs. As a LightSand customer, you will have the assurance thatyour technical issues will be resolved in a timely and efficient manner to help you keep your business running smoothly. | $7M / Jul 13, 2005 | |
|
Whole Optics
|
WholeOptics is a Micro-Electronic company developing core optical technology for Optical Broadband Communications. The company's main product is an innovative optical switch which is based on Bandgap engineering and on semiconductor processing knowledge. The switch has high speed switching capacity which suits various communicationapplications such as IMAP, Terabit Routers and High Speed Storages. The company's objective is to develop, design, produce and market the building blocks which will facilitate the implementation of End-to-End broadband optical networks. | $5M / Series B / May 15, 2005 | |
Remon Medical Technologies
|
Remon Medical Technologies is a development-stage company focused on communication technology for medical device applications. It offers RemonCHF, a device that monitors the hemodynamic status of patients with congestive heart failure; and RemonAAA, a device that monitors pressure following an endograft procedure in AAA patients.The company isbased in Caesarea, Israel. | $10M / Series C / Jan 10, 2005 | |
|
Remon Medical Technologies
|
Remon Medical Technologies is a development-stage company focused on communication technology for medical device applications. It offers RemonCHF, a device that monitors the hemodynamic status of patients with congestive heart failure; and RemonAAA, a device that monitors pressure following an endograft procedure in AAA patients.The company isbased in Caesarea, Israel. | $16M / Series C / Sep 24, 2004 | |
Miradia
|
Miradia designs and manufactures micro-electro-mechanical system (MEMS) products. The company, through its technology, integrates MEMS structures directly on complementary metal-oxide semiconductors and wafer scale packaging. Miradia was formerly known as XHP Microsystems, Inc. The company was founded in 2003 and is based in Sunnyvale, California.As of April 7, 2009, Miradia, Inc. operates as a subsidiary of Touch Micro-system Technology. | $22M / Series B / Aug 30, 2004 | |
FlexLight Networks
|
Founded in September 2000 by a dynamic team of high-powered and experienced optical network specialists, FlexLight's suite of optical access products leverages leading-edge technology to deliver a solution that conquers last-mile bandwidth bottlenecks and optimizes service flexibility.FlexLight's seed funding of $9 million comes fromAmerica's Coral Ventures, a private venture capital firm that manages more than $300 million of capital in five funds, and from Israel's Concord Venture Capital Fund, a firm that offers exceptional entrepreneurs the capital, guidance and industry contacts they need to become leaders in their field. | $15.3M / Series C / Jul 18, 2003 | |
Odin Medical Technologies
|
Odin Medical Technologies develops, manufactures and commercializes Intraoperative MRI systems designed for use by the neurosurgeon in standard ORs. The compact, open PoleStar N-10* is a real-time imaging and navigation system utilized during all stages of brain surgery. The unit offers the neurosurgeon the differentiation capabilities of MRIwithout restricting the freedom of the surgical team to access the patient. The Company�s mission is to improve neurosurgical interventions with minimally invasive procedures. *PoleStar N-10 is FDA cleared for intraoperative MR imaging in a conventional O.R. | $13M / Series B / Apr 01, 2002 | |
Healinx
|
Healinx is a unique medical relationship management application service provider (ASP). Our mission is to increase communication and the satisfaction level between patients and their doctors, while enhancing physician practice efficiency and profitability.By providing a Web-based channel that links patients directly to their personal doctors,Healinx allows patients to communicate with their doctors or access their medical information anytime -- from anywhere. In addition, patients can receive personalized health information from their doctors. The Healinx customized Internet messaging enables doctors and patients to communicate online with state of the art security and privacy. In addition, the Healinx channel includes a set of tools for electronic prescriptions and preventive care. | $13.1M / Series D / Aug 20, 2001 | |
Proficiency
|
Proficiency, Inc. provides product knowledge integration and CAD interoperability solutions that enable manufacturers and suppliers to share product knowledge from various engineering and manufacturing environments. Its solutions include product knowledge migration, which delivers a process of technology and methodology that meets migration needs;and supplier delivery solutions to original equipment manufacturers or higher tier suppliers. The company’s products also include Collaboration Gateway V7.0, which enables the transfer of the product knowledge between CAD systems that include geometry, features, sketches, manufacturing info, metadata, assembly information, and drawings in the conversion process; and Completion Wizard, which provides an interactive method of completing the process. In addition, it offers CAD translation services, such as geometry-only, product knowledge, and associative drawing translations; consulting services, such as migration strategy, supplier delivery strategy, and process integration consulting; and implementation services, such as training, customer support, and customer specific developments. The company serves various companies in the automotive, aerospace and defense, and heavy machinery industries.Proficiency, Inc. was founded in 1998 and is based in Marlborough, Massachusetts. As of July 1, 2009, Proficiency, Inc. operates as a subsidiary of ITI TranscenData. | $27.4M / Series C / Jun 10, 2001 | |
| See all 13 investments → | |||
Co-Investors
Genesis Partners
3 deals together
Polaris Partners
3 deals together
CRV
2 deals together
J.P. Morgan Securities Inc.
2 deals together
KBL Healthcare Ventures
2 deals together
Lilly Ventures
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
SaaS Investors
99,274 investors
Enterprise Investors
77,348 investors
Health Care Investors
43,014 investors
Climate Investors
40,325 investors
Hardware Investors
40,144 investors
Consumer Investors
32,380 investors
Manufacturing Investors
24,696 investors
Internet Investors
23,697 investors
Medical Investors
18,848 investors
FAQ
What does Concord Ventures invest in?
Concord Ventures invests primarily in Manufacturing, Medical and Electronics startups, most often at Series B and Series C stage. Most of the 13 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Concord Ventures?
Public channels for Concord Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Concord Ventures?
The team at Concord Ventures includes Avi Domoshevizki (General Partner), Galit Makmal (Accountant) and Isabelle Shai (Administrative Manager), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
